Zyneyro ApS: Financial statements 2024
CVR: 42057428
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Zyneyro ApS (CVR 42057428) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 4,168,667 and a net result of DKK 665,931 compared with DKK -34,534 the year before. That is an increase of 304.9% compared with the year before. Equity in the 2024 report amounted to DKK 613,816. The solvency ratio was 43.3%. The company had 5 employees in the financial year.
- Gross Profit
- DKK 4,168,667
- Profit/Loss
- DKK 665,931
- Equity
- DKK 613,816
- Total Assets
- DKK 1,416,828
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 4.2 mio. | 666 t. | 614 t. | 5 |
| 2023 | - | 1 mio. | -35 t. | -52 t. | 4 |
| 2022 | - | -27 t. | -28 t. | -18 t. | 0 |
| 2021 | - | -27 t. | -29 t. | 11 t. | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of November 1, 2024, Steen Søren Klysner is registered as director of Zyneyro ApS.
As of October 31, 2024, Peter Horn Møller has stepped down as director of Zyneyro ApS.
Zyneyro ApS has published its annual report for 2023. Gross profit came to DKK 1,029,558, and the net result was DKK -34,534.
About Zyneyro ApS
Zyneyro ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2021. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named DolorestBio ApS. The management consists of Steen Søren Klysner. The board consists of Jacob Ørndrup (chair), Andreas Toft Sørensen, Erik Vinther and Kenneth Lindegaard Madsen. The company's owners include Marigold Innovation ApS, IFO ApS and UGether ApS. The company has 10 employees (2026). In 2025, the company reported a gross profit of DKK -4,550,684 and a net result of DKK -7,466,446 compared with DKK 665,931 the year before. Equity in the 2025 report amounted to DKK 4,147,370.